Evidence map›Paper›PMID 39169028›Full record

ArticleNature communications2024

Adapting nanopore sequencing basecalling models for modification detection via incremental learning and anomaly detection.

Ziyuan Wang, Yinshan Fang, Ziyang Liu, Ning Hao, Hao Helen Zhang, Xiaoxiao Sun, Jianwen Que, Hongxu Ding

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Pseudouridylation landscape across 42bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. The Secret Life of NJournal of molecular biology · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The Precise Basecalling of Short-Read Nanopore Sequencing.bioRxiv : the preprint server for biology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ziyuan Wang *Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA.ORCID 0000-0002-2476-2929
Yinshan Fang *Columbia Center for Human Development, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Ziyang LiuDepartment of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA.
Ning HaoStatistics and Data Science GIDP, University of Arizona, Tucson, AZ, USA.ORCID 0000-0002-3104-5370
Hao Helen ZhangStatistics and Data Science GIDP, University of Arizona, Tucson, AZ, USA.
Xiaoxiao SunStatistics and Data Science GIDP, University of Arizona, Tucson, AZ, USA.
Jianwen QueColumbia Center for Human Development, Department of Medicine, Columbia University Medical Center, New York, NY, USA. jq2240@cumc.columbia.edu.ORCID 0000-0002-6540-6701
Hongxu DingDepartment of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA. hongxuding@arizona.edu.ORCID 0000-0002-7846-9744

Funding

Improve Lung Regeneration Through Targeting Tuft Cells Following Viral InfectionR01HL159675 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QUE, JIANWEN · 2021 to 2024
$2.4M
Cell Fate Regulation in Esophageal Progenitor CellsR01DK132251 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LU, CHAO, QUE, JIANWEN · 2022 to 2025
$2.3M
VEGF/KDR Signaling in Airway Epithelial Regeneration and DiseaseR01HL152293 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QUE, JIANWEN · 2021 to 2024
$2.0M
Protein Translation for Oxidative Stress Response in Heart FailureR01HL179676 · NHLBI · UNIVERSITY OF ARIZONA · PI QIN M CHEN · 2025 to 2026
$1.1M
Novel Mechanisms of Oxidative Stress Response in Heart FailureR56HL166330 · NHLBI · UNIVERSITY OF ARIZONA · PI CHEN, QIN M · 2023 to 2023
$625k
Tuft Cells Modulate Macrophage Response Following Lung Viral InfectionR21AI163753 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QUE, JIANWEN · 2022 to 2023
$446k
NHLBI NIH HHS R01 HL152293NHLBI NIH HHS R01 HL159675NHLBI NIH HHS R01 HL179676NHLBI NIH HHS R56 HL166330NIAID NIH HHS R21 AI163753NIDDK NIH HHS R01 DK132251
6 · The paper itself

Abstract

We leverage machine learning approaches to adapt nanopore sequencing basecallers for nucleotide modification detection. We first apply the incremental learning (IL) technique to improve the basecalling of modification-rich sequences, which are usually of high biological interest. With sequence backbones resolved, we further run anomaly detection (AD) on individual nucleotides to determine their modification status. By this means, our pipeline promises the single-molecule, single-nucleotide, and sequence context-free detection of modifications. We benchmark the pipeline using control oligos, further apply it in the basecalling of densely-modified yeast tRNAs and E.coli genomic DNAs, the cross-species detection of N6-methyladenosine (m6A) in mammalian mRNAs, and the simultaneous detection of N1-methyladenosine (m1A) and m6A in human mRNAs. Our IL-AD workflow is available at: https://github.com/wangziyuan66/IL-AD .

Indexed as

AdenosineEscherichia coliMachine LearningNanopore SequencingRNA, MessengerRNA, TransferAnimalsHumansSaccharomyces cerevisiae1-methyladenosineAdenosineN-methyladenosineRNA, MessengerRNA, Transfer

Identifiers

PMID39169028
PMCPMC11339354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.